COMPANY

Royer Biomedical

HQ: Frederick, MD source · royerbiomedical.com ↗ · Mid-Atlantic

Location: Frederick, MD · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Diabetic Foot Ulcers

Timeline

2014-01 Trial start Phase 1/Phase 2: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT02036528	Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers	Phase 1/Phase 2	Terminated	2014-01	2014-12 (actual)

Annual award amounts. Total $152K.

Dec 1, 2020 NIH award 1R01FD007246-01 FY2021: $86,071 awarded for that fiscal year; activity R01 (OTHER_NIH); PI BIZIKOVA, TATIANA; recipient as written: ROYER BIOMEDICAL, INC., FREDERICK, MD. Efficacy Study of Cisplatin Beads source ↗
Jan 5, 2015 NIH award 1R01FD005333-01 FY2015: $65,854 awarded for that fiscal year; activity R01 (OTHER_NIH); PI BIZIKOVA, TATIANA; recipient as written: ROYER BIOMEDICAL, INC., FREDERICK, MD. Target Animal Safety Study of Cispl source ↗